mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.03 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |
mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.03 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.03 |
mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.03 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.067 |
0.03 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.03 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.03 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.03 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.04 |